🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-center, Phase II trial designed to estimate i...
Status
Unknown
Location
Istituto Clinico Humanitas
Start Date
2020-01-30
Trial ID
NCT04435977
Treatments Being Tested
The goal of this clinical trial is to learn whether the antibiotic ceftoloz...
Status
Terminated
Location
Weill Cornell Medicine
Start Date
2023-01-10
Trial ID
NCT04673175
Treatments Being Tested
Hospitalization for elective knee or hip replacement surgery presents an ou...
Status
Completed
Location
New York University School of Medicine
Start Date
2019-01-15
Trial ID
NCT03673228
Background: Millions of people each year sustain injuries, have tumors surg...
Status
Recruiting
Location
Johns Hopkins University School of Medicine
Start Date
2011-07-21
Trial ID
NCT01459107
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
A prospective, randomized, placebo controlled, double-blinded study at a si...
Status
Terminated
Location
SJHMC/Barrow Neurosurgical Associates
Start Date
2015-03-01
Trial ID
NCT02276911
Treatments Being Tested
The relation between improvement in results of treating spontaneous intrace...
Status
Completed
Location
Pomeranian Medical University
Start Date
2017-03-17
Trial ID
NCT06094244
Treatments Being Tested
This is a randomized, double-blind, active drug- and placebo-controlled, do...
Status
Recruiting
Location
The Third Xiangya Hospital of Central South University
Start Date
2026-03-30
Trial ID
NCT07519109
Treatments Being Tested
This trial is a prospective, multi-center, randomized comparison study of 2...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04
Trial ID
NCT03834909
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested